For individuals with chronic illnesses who already suffer from compromised gastrointestinal tracts, dysbiosis, or malabsorption issues, standard oral powders or capsules are highly inefficient
Around 6% to 10% of patients stop treatment due to gastrointestinal side effects, and about 15% require dose adjustments
Every protocol is built into a medically supervised plan that includes nutrition support from a concierge dietitian on staff, ensuring each patient gets the most out of their peptide therapy
Also, further studies should assess whether SASP may be used for the prevention or the treatment of metastatic breast cancer
Compliance Considerations for Telehealth and Life Sciences Companies FDAs enforcement activity highlights several compliance risks for companies operating in the telehealth, compounding, and digital health sectors